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ABSTRACT
Eukaryotic ribosome biogenesis requires the
function of a large number of trans-acting factors
which interact transiently with the nascent
pre-rRNA and dissociate as the ribosomal subunits
proceed to maturation and export to the cytoplasm.
Loss-of-function mutations in human trans-acting
factors or ribosome components may lead to
genetic syndromes. In a previous study, we have
shown association between the SBDS
(Shwachman–Bodian–Diamond syndrome) and
NIP7 proteins and that downregulation of SBDS in
HEK293 affects gene expression at the transcrip-
tional and translational levels. In this study, we
show that downregulation of NIP7 affects
pre-rRNA processing, causing an imbalance of the
40S/60S subunit ratio. We also identified defects at
the pre-rRNA processing level with a decrease of
the 34S pre-rRNA concentration and an increase of
the 26S and 21S pre-rRNA concentrations,
indicating that processing at site 2 is particu-
larly slower in NIP7-depleted cells and showing
that NIP7 is required for maturation of the 18S
rRNA. The NIP7 protein is restricted to the nuclear
compartment and co-sediments with complexes
with molecular masses in the range of 40S–80S,
suggesting an association to nucleolar pre-
ribosomal particles. Downregulation of NIP7
affects cell proliferation, consistently with an im-
portant role for NIP7 in rRNA biosynthesis in
human cells.
INTRODUCTION
Biogenesis of eukaryotic ribosomes involves synthesis and
assembly of four ribosomal RNAs (rRNA) with about 80
ribosomal proteins mediated by more than 170 trans-
acting factors. A signiﬁcant amount of the cell energy is
devoted to the maturation of three of the four eukaryotic
rRNA molecules (18S, 5.8S and 25/28S) which are
generated from a single transcript containing the se-
quences of the mature rRNAs ﬂanked by spacer se-
quences. During rRNA maturation, the spacer sequences
are excised by a series of endo and exonucleolytic cleav-
ages and, at speciﬁc positions deﬁned by sequence com-
plementarity to snoRNAs, bases or riboses are modiﬁed
by methylation and uridines are converted to pseudourid-
ines (1–4). The pre-rRNA processing pathway is best
characterized in the Saccharomyces cerevisiae model
system. In wild-type strains, pre-rRNA maturation
follows a 50 to 30 processing hierarchy where the 50 ETS
(external transcribed spacer sequence) is cleaved before
processing in ITS1 (internal transcribed spacer
sequence 1), which in its turn is cleaved before ITS2 (5–7).
Most of the yeast ribosome biogenesis factors have
counterparts in higher eukaryotes, although not all the
data obtained from the yeast system can be transferred
to vertebrates. For instance, pre-rRNA maturation does
not follow the 50 to 30 processing hierarchy in vertebrates.
Instead, the order of processing depends on the species,
cell type and physiological state. The mammalian
pre-rRNA can be processed by simultaneous alternative
pathways (8,9), following an initial cleavage that takes
place at the site A0 of the 47S pre-rRNA generating the
45S pre-rRNA. The three major pathways differ in the
place of the ﬁrst processing step in the 45S pre-rRNA.
In pathway A, the ﬁrst cleavage takes place at Site 1, in
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(Figure 1). The pathway has continuously been reviewed
and novel intermediates and a cleavage site in the 50-ETS
have recently been described for mouse and human cells
(10,11).
Expression of genes encoding ribosome biogenesis
factors (termed Ribi regulon) is tightly regulated,
showing a coordinated response to nutrient supply,
physiological conditions or genetic perturbations
(12–15). Transcription of this group of genes requires con-
certed action of the three RNA polymerases which in
animals is mediated by the transcription factor Myc
(16–19). Synchronized expression of the Ribi regulon
involves also feedback regulation by several ribosomal
proteins (20–22). Accurate synthesis of ribosomes is
critical to all cells. Mutations in S. cerevisiae genes
required for ribosome biogenesis usually interfere with
the order of pre-rRNA processing steps, causing accumu-
lation of aberrant pre-rRNAs or fast degradation of
pre-rRNA intermediates. Pre-rRNA processing defects
can also lead to imbalance of the 40S/60S subunit ratio
or affect subunit export to the cytoplasm. In humans, mu-
tations causing loss of function in genes encoding struc-
tural proteins or ribosome biogenesis factors may lead to
genetic syndromes. Currently, there are ﬁve known syn-
dromes associated with mutations in such genes. A series
of mutations in genes encoding both 40S subunit (23–25)
and 60S subunit proteins (26–28) have been linked to the
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Figure 1. Schematic representation of the human pre-rRNA processing pathways. The 47S pre-rRNA is converted to the 45S pre-rRNA following
the initial cleavages at sites A0 in the 50-ETS and at site 6, at the 30-end of the mature 28S rRNA. The 45S is processed by three alternative pathways.
In pathway A, the ﬁrst cleavage in 45S takes place at site 1, generating the 41S pre-rRNA whose 50-end corresponds to the 50-end of the mature 18S
rRNA. The 41S pre-rRNA is subsequently processed at site 2c, separating the 21S pre-rRNA, from the 32S pre-rRNA. The 30-end of the 21S
pre-rRNA is processed to generate the 18S rRNA. The 32S pre-rRNA is cleaved at site 4b, generating the 12S pre-rRNA and the 28S rRNA. Finally,
the 30-end of the 12S pre-rRNA is processed to generate the mature 5.8S rRNA. In pathway B, the ﬁrst cleavage in 45S takes place at site 2c,
generating the 34S and 32S pre-rRNAs. The 34S pre-rRNA is subsequently processed at site 1, generating the 21S pre-rRNA. The 30-end of the 21S
pre-rRNA is processed further to generate the 18S rRNA. The 32S pre-rRNA is processed as described for pathway A. In pathway C, the ﬁrst
cleavage in 45S takes place at site 4b, generating the 37S and the 28S rRNA. The 37S pre-rRNA is subsequently processed at site 1, generating the
26S pre-rRNA, which is subsequently cleaved at site 2 generating the 18S rRNA and the 17S pre-rRNA. This pre-rRNA is processed at site 3
generating the 12S pre-rRNA and the 30-end of the 12S pre-rRNA is processed to generate the mature 5.8S rRNA. This representation of the
pathways was based on the papers published by Bowman et al. (8) and Hadjiolova et al. (9). Open arrowheads indicate the subsequent cleavage sites.
Dark arrowheads (P1–P7) underneath the 47S pre-rRNA indicate the positions of the oligonucleotide probes used in northern blot and the open
arrows (PE1–PE3) indicate the oligonucleotide probes used in primer extensions analyses, respectively.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 649Diamond Blackfan Anemia (DBA). In addition,
Dyskeratosis Congenita has been associated with muta-
tions in the X-linked DKC1 gene (29), encoding
dyskerin, the pseudouridine synthase component of box
H/ACA snoRNP. Deﬁciency in dyskerin abrogates
pseudouridylation of rRNA and affects translation initi-
ation of mRNAs containing internal ribosomal entry sites
(IRES) (30,31). Mutations in the RNA component of the
RNase MRP have been linked to Cartilage–Hair
hypoplasia (CHH) (32). Mutations in the gene encoding
the protein treacle are linked to the Treacher Collins
syndrome. Treacle interacts with RNA polymerase I and
Nop56, a subunit of the box CD snoRNP, and is involved
in rRNA methylation (33,34). The Shwachman-
Bodian-Diamond syndrome (SDS) is associated to muta-
tions in the SBDS gene (35). Studies using both yeast and
human cells have shown that SBDS orthologs are involved
in ribosome biosynthesis and function (36–38).
Dysregulation of ribosome biosynthesis and translational
capacity has also been associated to pathological condi-
tions such as human breast cancer (39).
The S. cerevisiae NIP7 protein is required for pre-rRNA
processing and ribosome biosynthesis (40). NIP7
orthologs are highly conserved, ranging from 160 to 180
amino-acid residues and sharing a two-domain architec-
ture with the C-terminal region corresponding to the PUA
domain (named after pseudouridine synthases and
archaeosine-speciﬁc transglycosylases) with a predicted
RNA-interaction activity (41) that in the case of the
Pyrococcus abyssi and S. cerevisiae NIP7 orthologs was
already conﬁrmed (42). The human NIP7 interacts with
Nop132 (43), the putative ortholog of the S. cerevisiae
Nop8p that is also involved in ribosome biogenesis (44).
Furthermore, the human NIP7 was found in complexes
isolated by afﬁnity-tagged puriﬁcation of RPS19 (45), a
component of the 40S subunit that plays an essential
role in its synthesis (23), and of parvulin (Par14), a
peptidyl-prolyl cis–trans isomerase (PPIase) required for
pre-rRNA processing (46). In a previous work, we have
detected the interaction of NIP7 with SBDS in the yeast
two-hybrid system (47). In addition, an immobilized
GST–SBDS fusion protein was able to pull-down NIP7
from HEK293 cell extracts, indicating that both proteins
can be part of a multisubunit complex (47).
Although the evidence above points to a role for the
human NIP7 protein in ribosome biosynthesis, so far
there is no report on the functional analysis of this
protein. In this work, we used RNA interference to
downregulate NIP7 and investigate its function in
human cell lineages. We show that downregulation of
NIP7 affects cell proliferation and causes imbalance of
the 40S/60S subunit ratio. We also identiﬁed defects at
the pre-rRNA processing level with a decrease of the
34S pre-rRNA concentration and an increase of the 26S
and 21S pre-rRNA concentrations, suggesting that pro-
cessing at site 2 is particularly slower in NIP7-depleted
cells. The results presented in this work suggest that
NIP7 is required for accurate processing of the
pre-rRNAs leading to 18S rRNA maturation and 40S
subunit biogenesis. At least part of the pre-rRNA process-
ing defects caused by NIP7 downregulation have been
described for other situations in which ribosome biogen-
esis was impaired, such as treatment with leptomycin B,
which inhibits exportin Crm1/Xpo1 and blocks ribosome
subunit export from the nucleus, and for downregulation
of 40S biogenesis factors (11). The NIP7 protein is re-
stricted to the nuclear compartment and co-sediments
with complexes with molecular masses in the range of
40S–80S suggesting an association to nucleolar
pre-ribosomal particles. This work shows that NIP7
plays a critical role in pre-rRNA maturation in human
cells.
MATERIALS AND METHODS
Plasmid construction
DNA cloning was performed using the Escherichia coli
strain DH5a which was maintained in LB medium con-
taining 50mgml
 1 of the required antibiotic used in
transformant selection and manipulated according to
standard techniques (48). The NIP7 540-bp coding
sequence was isolated from pTL1-HSNIP7 (47) using the
EcoRI/SalI restriction sites and inserted into the pET28a
plasmid, generating pET28-HSNIP7. The NIP7 shRNA
target was 21-residue oligonucleotide whose sequence
was selected based on the Ambion siRNA Target
Finder. The sequences of the oligonucleotides
NIP7-shRNA-F and NIP7-shRNA-R used to generate
the shRNA against the NIP7 mRNA and of the oligo-
nucleotides scrambled shRNA-F and scrambled
shRNA-R to generate the control scrambled shRNA,
scRNA, is given in Table 1. The annealed oligonucleotides
were cloned into pMaleﬁcent (49) previously digested with
Esp3I/EcoRI, generating pMaleﬁcent-shRNA-HSNIP7
and pMaleﬁcent-scRNA-HSNIP7, respectively.
Cell culture methods and RNA interference strategies
HEK293 cells (ATCC number CRL-1573) were main-
tained in MEM (Minimum Essential Alfa Medium,
Gibco-BRL) supplemented with 10% fetal bovine serum,
100U.ml
 1 penicillin and 100mg.ml
 1 streptomycin. The
cells were cultured at 37 C in a humidiﬁed atmosphere
with 5% CO2. To generate permanent cells with
downregulation of NIP7, we employed a mammalian
transposon system designated pMaleﬁcent/
pCMVHSB#17 (49). HEK293 transfections were per-
formed by electroporation as described by Klan and
Steinhilber (50). Following transfection, HEK293 cells
were transferred into six-well plates and kept under
geneticin selection (700mg.ml
 1). Proliferation rates of
HEK293 derivative cells were determined using the
MTT {[3-(4,5-dimethylthiazolyl-2)-2,5-diphenytetra-
zolium bromide], Sigma} cell proliferation assay as previ-
ously described (47). Downregulation of NIP7 in HeLa
and MCF10A cells was achieved by using transient trans-
fections of siRNA. For each assay, 1.5 10
5 cells
( 60–80%conﬂuence) were harvested in OPTI MEM
(Invitrogen) and transfected with 5 or 10nM siRNA
oligonucleotides (NIP7-siRNA-F and NIP7-siRNA-R,
Table 1) using 0.5ml/ml lipofectamine RNAiMax
Transfection Reagent (Invitrogen) following the
650 Nucleic Acids Research, 2011,Vol. 39,No. 2manufacturer’s instructions. Parallel control transfection
assays were performed with scrambled ‘AllStars Negative
Control siRNA’ (Qiagen); Cells were plated and cultured
for 12h in antibiotic free medium. Medium was changed
and cells cultured for 36–96h in complete fresh medium.
For proliferation analysis of transfected HeLa and
MCF10A cells, triplicates at a density of 1500cells/well
were seeded in 96-wells plates (100ml/well) and cultured
for 4h in complete medium. At each time point, cells were
treated with 10ml Uptiblue (Interchim) and incubated for
4h at 37 C. Luminescent quantiﬁcation was performed
using a spectrophotometer (Cytoﬂuor), excitation 590/
25nm; emission 530/25nm. Background was measured
from wells without cells and subtracted from the 530nm
values. Cell-cycle analyses were performed by
ﬂuorescence-activated cell sorting (FACS). For these
assays, 0.5 10
6 cells were ﬁxed on ice in 70% (v/v)
ethanol for 30min, washed with PBS and the DNA
content stained with 20mg/ml propidium iodide in PBS
in the presence of 1mg/ml RNAse. Cells were analyzed
on a FACSCalibur
TM
(BD Biosciences) equipped with a
488-nm argon laser. The ﬂuorescence was measured
through a 575/25 band pass ﬁlter. Cells doublets were
removed using the FL2-Area and FL2-Width parameters.
Data acquisition was performed using CellQuest software
(BD Biosciences) and analysis using ModFit software
(Verity Software). FACS analyses were performed with
the permanent HEK293 derivative cells (SC, which
express the scrambled shRNA and, CP4 cells that
express the RNAi against the NIP7 mRNA) and with
MCF10A cells transiently transfected with either a
scrambled siRNA or a NIP7 siRNA 48h after
transfection.
Analysis of NIP7 mRNA levels
NIP7 mRNA downregulation was conﬁrmed by RT–
qPCR using oligonucleotides complementary to NIP7
sequence (NIP7-shRNA-F and NIP7-shRNA-R). One
microgram of total RNA was used for cDNA synthesis
using the SuperScript II Reverse Transcriptase system
(Invitrogen). The mRNA levels were quantiﬁed using the
SYBR Green reagent on a 7500 Real Time PCR system
(Applied Biosystems). In the case of HEK293 derivative
cells, NIP7 mRNA levels were normalized to the amount
of the actin mRNA determined using primers Actin-F and
Actin-R. In the case of HeLa and MCF10A cells, NIP7
Table 1. Primers used in this study
Primer name Sequence
NIP7-shRNA-F 50 TCC CGA ACC ATG TGT TGA AAT CTG GTT TCA AGA GAA CCA GAT TTC AAC ACA TGG
TTC TTT TTT G 30
NIP7-shRNA-R 50 AAT TCA AAA AAG AAC CAT GTG TTG AAA TCT GGT TCT CTT GAA ACC AGA TTC AAC
ACA TGG TTC 30
Scrambled shRNA-F 50 TCC CGA ATT TGT GAT CCA GGA ATG CTT TCA AGA GAA GCA TTC CTG GAT CAC AAA
TTC TTT TTT G 30
Scrambled shRNA-R 50 AAT TCA AAA AAG AAT TTG TGA TCC AGG AAT GCT TCT CTT GAA AGC ATT CCT GGA
TCA CAA ATT C 30
NIP7-siRNA-F 50 GCA CCU ACU GUU UCC GUC UGC ACA A 30
NIP7-siRNA-R 50 UUG UGC AGA CGG AAA CAG UAG GUG C 30
Actin-F 50 TGG ATC AGC AAG CAG GAG TAT G 30
Actin-R 50 GCA TTT GCG GTG GAC GAT 30
NIP7-F 50 CCG GGT GTA CTA TGT GAG TGA GAA 30
NIP7-R 50 TTG TGG GTT TTA GTG AAT TTT CCA 30
HPRT-F 50 TGA CCT TGA TTT ATT TTG CAT ACC 30
HPRT-R 50 CGA GCA AGA CGT TCA GTC CT 30
36B4-F 50 GTG TTC GAC AAT GGC AGC AT 30
36B4-R 50 GAC ACC CTC CAG GAA GCG A 30
P1 50 CCC CAA GGC ACG CCT CTC AGA TCG CTA GAG AAG GCT TTT C 30
P2 50 CCA CGC AAA CGC GGT CGT CGG CAC CGG TCA CGA CTC GGC A 30
P3 50 AAG GGG TCT TTA AAC CTC CGC GCC GGA ACG CGC TAG GTA C 30
P4 50 GCG TTC GAA GTG TCG ATG ATC AAT GTG TCC TGC AAT TCA C 30
P5 50 CGG GAA CTC GGC CCG AGC CGG CTC TCT CTT TCC CTC TCC G 30
P6 50 GGG GAG AGG CGA CGG GAG AGA GAG CGC 30
P7 50 CTT TTC CTC CGC TGA CTA ATA TGC TTA 3
PE1 50 GAC ATG CAT GGC TTA ATC TTT GAG ACA AGC 30
PE2 50 GTA AAG CCC CCA CCC GAC GGC CGC CG 30
PE3 50 CTC GCA GCT AGC TGC GTT CTT CAT CGA C 30
MM21 50 CAC AAG CCC ATT TGA CAC TGA 30
MM30 50 CGG AAT TCC GTG GGC CTA AGT CAG ATG ATG 30
MM36 50 CTC GAG TTA TTC ATC AAA AAT TTG GAT TGG TAT TTC 30
MM44 50 CTG CAG CTC GAG TTA CCT TCG TGT ATA TTC TTC TGA TTT TTA TG 30
MM54 50 CTC GAG TCA ACT TTC AAG TAC AGA TGG AGC CAC ATA TTC AAA ACC CAG AAA GAC 30
MM64 50 AAT TCA AAA AAG AAT TTG TGA TCC AGG AAT GCT TCT CTT GAA AGC ATT CCT GGA
TCA CAA ATT C 30
MM74 50 TCC CGT ATA ATC TGT TGT ATA GGT CCT TGA TAT CCG GGA CCT ATA CAA CAG ATT
ATA TTT TTT CCA ATT TTT TG 30
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HPRT and 36B4 mRNAs, respectively, which were
determined using primers HPRT-F and HPRT-R or
36B4-F and 36B4-R, respectively. The sequences of all
primers used in this work are given in Table 1. The
NIP7 protein levels were determined by immunoblotting
as described below.
Sucrose gradient and cell fractionation
Polysomes proﬁles were analyzed on sucrose gradients as
previously described (51). The cells were cultivated up to
50% conﬂuence. Following addition of 100mg.ml
 1
cycloheximide, 5 10
7 cells were collected and lyzed
using 500ml of polysome buffer (PB) containing 20mM
Tris–HCl pH 7.5, 100mM NaCl, 10mM MgCl2,1 m M
DTT, 1% v/v Triton X-100 and 100mg.ml
 1
cycloheximide. Extracts were clariﬁed by centrifugation
at 20000 g for 10min at 4 C. Totals of 255 OD260
units (300ml) were loaded onto linear sucrose gradients
(15–50%) prepared in PB. Polysomes were separated by
centrifugation at 40000rpm for 4h at 4 C using a
Beckman SW41 rotor. Gradients were fractionated by
monitoring absorbance at 254nm. Protein precipitation
and removal of sucrose for immunoblot analyses was per-
formed as follows: 150ml of each sucrose gradient fraction
were mixed with 600ml of methanol and subsequently
mixed with 150ml of chloroform; 450ml of water were
added to the mix and centrifuged at 20000 g for 5min
at 4 C. The aqueous layer was discarded and the pellet
washed with 650ml of methanol, followed by centrifuga-
tion as described above. The liquid was discarded and the
pellet was taken up in protein sample buffer (48) and
analyzed by immunoblotting. For isolation of nuclear
and cytoplasmic extracts, 2 10
7 cells were washed in
ice cold PBS and harvested by centrifugation at 500 g
for 5min at 4 C. Cells were lyzed in 1ml LSB (10mM
Tris–HCl pH 7.4, 320mM sucrose, 2mM MgCl2,3 m M
CsCl2, 0.4% NP-40, 1mM DTT) containing a protease
inhibitor cocktail (Roche) for 12min on ice.
Subsequently, the lysate was centrifuged at 800 g for
2min at 4 C, the supernatant was collected and
centrifuged at 20000 g for 10min and the resulting
supernatant was saved as the cytoplasmic extract. The
pellet from the 800 g centrifugation, containing the
nuclei, was washed once with LSB and the nuclear
proteins extracted in 300ml HSB (250mM NaCl, 50mM
Tris–HCl pH 8.0, 5mM EDTA pH 8.0, 0.5% NP-40) con-
taining a protease inhibitor cocktail (Roche) and 240U of
RNaseOUT (Invitrogen). The suspension was centrifuged
at 20000 g for 10min at 4 C and the supernatant saved
as the nuclear fraction. Totals of 10 OD260 units of nuclear
extracts were fractionated on 15–50% sucrose gradients
prepared in polysome buffer as described above. For im-
munoblotting, aliquots of sucrose gradient fractions were
processed as described above.
Immunoblot analysis
Proteins were resolved by SDS–PAGE and transferred to
PVDF membranes at 80mA for 1h in buffer containing
25mM Tris–base, 200mM glycine and 20% methanol.
Subsequently, membranes were blocked for 2h with
TBST buffer (20mM Tris–HCl pH 7.5, 150mM NaCl,
0.05% Tween 20) containing 5% low fat milk. The blots
were incubated at room temperature for 2h with primary
antibodies and for 1h with secondary antibodies.
Polyclonal antisera for the human NIP7 protein were
produced in rabbits and used at a 1:5000 dilution.
Rabbit polyclonal antibodies for RPS6, cytoskeletal
actin and GAPDH (Bethyl Laboratories) were used at a
1:5000 dilution. Mouse monoclonal for Lamin A/C and
alpha-tubulin (Santa Cruz Biotechnology) were used at a
1:300 and 1:2500 dilutions, respectively. The secondary
antibodies used were horseradish peroxidase-conjugated
goat anti-mouse IgG (Calbiochem) and donkey
anti-rabbit IgG (GE Healthcare) both at 1:5000 dilutions.
The immunoblots were developed using the ECL western
blotting analysis system (GE Healthcare).
RNA analysis
Total RNA from HEK293 cells, scRNA and
shRNA-NIP7 clones were isolated by Trizol extraction
(Invitrogen). RNAs were fractionated by electrophoresis
on 1.2% (w/v) agarose/formaldehyde gels, followed by
transfer to Hybond nylon membranes (GE Healthcare).
Northern blot was performed using [
32P]-labeled oligo-
nucleotide probes (P1–P7) complementary to speciﬁc
regions of the 47S precursor RNA and submitted to auto-
radiography. The position of the probes were based on the
human ribosomal DNA complete repeating unit,
Genebank accession number U13369 (version U13369.1,
GI:555853). The positions of the probes are as follows: P1
(50ETS), complementary to nt 1401–1442; P2 (50ETS),
complementary to nt 1786–1825; P3 (ITS1), complemen-
tary to nt 6121–6160; P4 (5.8S), complementary to nt
6690–6729; P5 (ITS2), complementary to nt to 7031–
7070; P6 (ITS2), complementary to nt 7812–7838 and;
P7 (28S), complementary to nt 7971–7997. Primer exten-
sion analysis was performed according to Gonzales et al.
(52) using oligonucleotide probes PE1 (18S), complemen-
tary to nt 3685–3714, PE2 (ITS1), complementary to nt
6299–6324 and PE3 (5.8S), complementary to nt 6655–
6682 (Table 1). [
32P]-labeled-oligonucleotides MM21,
MM30, MM36, MM44, MM54, MM64 and MM74
(Table 1) were used as molecular markers corresponding
to 21, 30, 36, 44, 54, 64 and 74nt, respectively. For meta-
bolic labeling of RNA, HEK293 cells cultured on 100-mm
plates at  70–80% conﬂuence were pre-incubated for
30min in phosphate-free DMEM (GIBCO) supplemented
with 10% FCS. Subsequently, [
32P]-orthophosphate
(15mCi/ml) was added to the cultures that were incubated
for 45min and the medium was replaced by cold MEM
(GIBCO) supplemented with 10% FCS. Cells were col-
lected at time 0, 30, 60 and 120min after changing the
medium. Total RNA was extracted with Trizol
(Invitrogen), and 10mg were separated by electrophoresis
on agarose/formaldehyde gels and revealed by autoradi-
ography. RNA was extracted from sucrose gradient frac-
tions as follows: 700ml of each fraction were transferred to
1.5ml tubes and 42ml of a 10% SDS solution was added
to obtain a ﬁnal SDS percentage of 0.6. The suspension
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700ml of phenol/chloroform/isoamyl alcohol (25:24:1) and
the second with phenol/chloroform (1:1) and the aqueous
phase was transferred to a new tube and the RNA
precipitated with 700ml of isopropanol for 1h at  20 C.
The RNA was sedimented by centrifugation (12000 g
for 10min at 4 C). The RNA pellet was washed with
75% ethanol, air dried and suspended in 10mlo f
DEPC-treated water.
Electrophoretic mobility shift assays (EMSA)
For recombinant NIP7 protein production, we used
plasmid pET28-HSNIP7, which was constructed by
transferring the 540-bp NIP7 coding sequence from
plasmid pTL1-HSNIP7 (47) to plasmid pET28a, using
the EcoRI/SalI restriction sites. Expression of NIP7 was
performed in E. coli BL21(DE3) cells transformed with
vector pET28-HSNIP7 and incubated in LB medium con-
taining kanamycin (50mgml
 1)a t2 5  C. At an OD600 of
 0.8, the culture was induced by adding 0.5mM IPTG
and incubating at 25 C for further 4h. Cells were har-
vested by centrifugation, suspended in buffer containing
50mM sodium phosphate pH 7.2, 100mM NaCl, 10%
glycerol and 0.5mM phenylmethylsulfonyl ﬂuoride
(PMSF) and treated with lysozyme (50mgml
 1) for
30min on ice. Subsequently, the cells were disrupted by
sonication and the histidine-tagged NIP7 puriﬁed by
metal-chelating afﬁnity chromatography, using a
20–200mM imidazole gradient for elution. NIP7 was
further puriﬁed on a heparin–sepharose column using
the same buffer as above for binding and a 50mM to
1M KCl gradient for elution. For EMSA, 20pmol of
the RNA oligoribonucleotides poly-A(20), poly-U(20) and
poly-AU(21),( 5 0 UUA UUA UUU AUU UAU UAU
UUA 30) were [
32P]-labeled using 1U T4 PNK and
20mCi [g
32P]-ATP. 0.4pmol of [
32P]-labeled oligoribo-
nucleotide was incubated with the indicated concentra-
tions of NIP7 in buffer A (20mM Tris–Cl pH 8.0, 5mM
magnesium acetate, 150mM potassium acetate, 0.2% v/v
Triton X-100, 1mM DTT, 1mM PMSF) for 30min at
37 C. Complexes were resolved on 8% polyacrylamide
gels using TBE buffer pH 8.0 for electrophoresis and
visualized by autoradiography. RNA competition assays
were performed with 1, 5 and 10pmol of either poly-A(20)
or poly-AU(21) oligonucleotides.
RESULTS
Knockdown of NIP7
The strategy to generate HEK293 cells knockdown for
NIP7 was based on the generation of stably-transfected
cells expressing a shRNA targeting the NIP7 mRNA
using pMaleﬁcent as shRNA delivery vector (49). The ef-
ﬁciency of NIP7 downregulation was determined by
analysis of the NIP7 mRNA and protein levels.
Quantitative RT–PCR indicated that the reduction of
NIP7 mRNA levels reached up to 80% of the parental
and control cells (Figure 2A). Although the levels of the
NIP7 mRNA are similar in clones CP4 and CP6, the re-
duction in NIP7 protein levels was more efﬁcient in clone
CP4 as observed by western blot analysis (Figure 2C).
Downregulation of NIP7 in these clones was stable over
the period of this study. CP4 cells showed signiﬁcant re-
duction of the proliferation rate (Figure 2E).
RNA interference based on transient transfection of
siRNA oligoribonucleotides was used to downregulate
NIP7 also in MCF10A and HeLa cells. The NIP7
mRNA levels were reduced to levels <10% of control
cells (Figure 2B). In siRNA-treated cells, NIP7 protein
was below the detection level as determined by immuno-
blotting. A signiﬁcant reduction in the proliferation rate of
both cell lines was observed following transfection with
the NIP7 siRNA (Figure 2F). The reduced proliferation
rate prompted us to perform ﬂuorescence-activated cell
sorting (FACS) to investigate cell-cycle progression in
these cells. In the case of the permanently transfected
HEK293 derivative cells, CP4 show the highest number
of cells in the G0–G1 phases and the lowest number in
the S phase (Table 2). This effect on the cell cycle, despite
of being mild, is consistent with the results observed for
MCF10A cells. NIP7 downregulation in MCF10A
resulted in an increase of cells in the G0–G1 phases with
an equivalent reduction of the number of cells in the S
phase (Table 2). This result shows that downregulation
of NIP7 lead to accumulation of cells in the G1–S
transition.
Analysis of polysomes in HEK293 cells depleted of NIP7
Defects in ribosome biogenesis can in some cases be
detected by using sucrose density fractionation of poly-
somes especially when there is an imbalance in the 40S/
60S subunit ratio. The CP4 clone, showing lower NIP7
levels, was chosen for further characterization.
NIP7-depleted CP4 cells showed signiﬁcant reduction of
40S ribosomal subunits (Figure 3C and D). This ﬁnding is
consistent with the cell proliferation assay and suggests
that the reduction in growth rate is due to defective 40S
subunit biosynthesis.
Analysis of pre-rRNA processing intermediates in NIP7
deﬁcient cells
Steady-state analysis of pre-rRNA processing was
assessed by northern blotting using probes complementary
to the transcribed spacer sequences and to the mature
rRNAs. The boundaries of most pre-rRNAs intermediates
relevant to this work have already been mapped (8–11). A
set of northern blots was performed with probes P1, P2,
complementary to the 50-ETS upstream and downstream
of Site A0, respectively, and with probe P3 complementary
to ITS1, upstream Site 2b (Figure 4). A second set of
northern blots was performed with probes P4–P7 that
are complementary to the 5.8S rRNA to ITS2 upstream
and downstream Site 4b and to the 28S rRNA, respect-
ively (Figure 5).
The precursors most affected are the 21S, 26S/A0-2c
and 34S with the 21S and 26S/A0-2c pre-rRNAs
showing increased levels and the 34S pre-rRNA showing
reduced levels in NIP7 deﬁcient cells (Figure 4). The 26S
pre-rRNA running slightly faster than the mature 28S
rRNA is detected with probes P2 and P3 but not by
Nucleic AcidsResearch, 2011, Vol.39,No. 2 653probe P1 and therefore extends from Sites A0 to 2c
(Figure 4B, C and E). We concluded that this pre-rRNA
corresponds to the 26S pre-rRNA described by Rouquette
and co-workers (11) who deﬁned its extension as from site
A0 to a site in ITS1 downstream of nt 5687 and upstream
of nt 6613, which must correspond to either Site 2b or 2c.
Another precursor named 26S pre-rRNA, extending from
Sites 1 to 4b, was described for pathway C [Figure 1, (8)].
However, the possibility that this pre-rRNA is increased
was excluded because it was not detected by probes P4 and
P5 (Figure 5). Probes P1–P3 can detect both the 34S and
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Figure 2. Analysis of NIP7 knockdown. (A) NIP7 mRNA levels as determined by quantitative RT–qPCR in HEK293 derivative cells. HEK293,
parental cells; SC, cells transfected with a scrambled shRNA; CP4 and CP6, cells transfected with shRNA against the NIP7 mRNA. NIP7 mRNA
quantitation was performed using three different RNA extractions from clones CP4 and CP6. (B) NIP7 mRNA levels in transiently
transfected MCF10A and HeLa cells. SC, control cells transfected with scrambled RNA; SiRNA, cells transfected with siRNA against NIP7.
The histogram corresponds to one of the three independent transfections of MFC10A and HeLa cells using three replicates for each cell treatment.
The amount of NIP7 mRNA in cells treated with the scrambled shRNA was considered as 100% to calculate its relative levels in the parental cells
(HEK293) and in cells expressing the RNAi against the NIP7 mRNA (CP4) or in cells transfected with siRNA against the NIP7 mRNA.
(C) Immunoblot showing the levels of the NIP7 protein in HEK293 derivative cells b-actin was used as an internal control. (D) Immunoblot
using antiserum for the NIP7 protein in transiently transfected MCF10A and HeLa cells. (E) Proliferation rate of HEK293 derivative cells expressing
the scrambled shRNA (SC) and the RNAi against the NIP7 mRNA (CP4) over a 7-day period. (F) Proliferation rate of transiently transfected
MCF10A and HeLa cells. The graphs correspond to one of the two independent proliferation assays performed using three replicates for each cell
treatment.
Table 2. Cell-cycle distribution of NIP7-depleted cells
Cell type Cell-cycle distribution (%)
G0/G1 S G2
HEK293 49 37 14
HEK293/SC 43 42 15
HEK293/CP4 51 33 16
MCFA10A/SC 47 35 18
MCFA10A/RNAi 73 13 14
Percentage numbers represent the average of three independent
experiments.
654 Nucleic Acids Research, 2011,Vol. 39,No. 2the 37S pre-rRNAs while probes P4 and P5 can detect
both the 37S and the 32S pre-rRNAs (Figures 4 and 5).
The 34S and 37S pre-rRNAs, comprising respectively
 6000 and  7520nt, may migrate with similar electro-
phoretic mobility in these gels. In the case of probes P1–
P3 (Figure 4), a strong reduction of the signal is observed
in this region of the northern blots, indicating that if any
37S pre-rRNA is generated in this cells its concentration is
also decreased in NIP7-depleted cells.
A reduction in the concentration of the 32S pre-rRNA
can be visually detected in the northern blots with probes
P5, P6 and P7 in the NIP7 deﬁcient cell line (Figure 5).
The levels of the 41S pre-rRNA are slightly increased in
NIP7 deﬁcient cells (Figures 4C, E, 5A–C and F). This
pre-rRNA, extending from sites 1 to 6, corresponds to
the second largest band detected by probes P3–P6
(Figures 4C, E, 5A–C and F). The levels of the 47S and
45S pre-rRNAs, on the other hand, show a slight decrease
in NIP7 deﬁcient cells (Figures 4A–E and 5F).
Accumulation of the 26S/A0-2c pre-rRNA has been
described in situations in which there is uncoupling of
processing at Sites 1 and 2. Leptomycin B (LMB)
inhibits exportin Crm1/Xpo1 and blocks ribosome
subunit export from the nucleus. We have analyzed
pre-rRNA processing of control cells (SC) and NIP7
shRNA cells (CP4) treated with LMB (Figure 4F).
Upon a 4h LMB treatment, SC cells showed a sharp
increase of the 26S/A0-2c pre-rRNA. In CP4 cells, that
already contain increased levels of the 26S/A0-2c and
21S pre-rRNAs, LMB treatment has a small effect on
the accumulation of the 26S/A0-2c pre-rRNA.
Accumulation of the 26S/A0-2c is consistent with slower
processing of sites 1 and 2 in NIP7-depleted cells.
However, accumulation of the 21S pre-rRNA and of the
41S pre-rRNA indicates that processing at sites 2c/2b and
2 are even slower that at site 1, suggesting that NIP7 is
particularly required for processing of the ITS1 sites.
Northern blot analysis with probe P3 was performed
also with RNA samples from MCF10A cells
(Supplementary Data), which detected accumulation of
the 21S and 41S pre-rRNAs following downregulation
of Nip7, indicating that Nip7 plays an important
function in all cell types.
The 37S pre-rRNA (spanning from Sites A0 to 4b) and
the 17S pre-rRNA (spanning from Sites 2b to 4b) would
be generated only if the pathway C proposed by Bowman
and co-workers (8) is indeed taking place in HEK293 cells.
Gel electrophoreses used in this work resolved the 28S
rRNA (5035nt) from the 26S/A0-2c pre-rRNA
( 4642nt). Therefore, it would be expected that the 37S
pre-rRNA ( 7520nt) would also be separated from the
32S pre-rRNA (6337 bases from sites 3 to 6). However,
probes 4 and 5 detected only one band in this region sug-
gesting that HEK293 cells produce low levels of the 37S
pre-rRNA. The 17S pre-rRNA could be detected by
probes P3, P4 and P5 (Figures 4C, 5A and B) but only
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Figure 3. Analysis of polysomes by sucrose density gradient fractionation. (A) Polysome proﬁle of HEK293 cells. (B) Polysome proﬁle of control
cells expressing the scrambled shRNA. (C) Polysome proﬁles of clone CP4 transfected with shRNA targeting the NIP7 mRNA. (D) Quantitation of
the 60S/40S subunit ratio of HEK293 cells, control scrambled shRNA cells (SC) and of CP4 cells in the polysome proﬁles shown in A, B and C,
respectively. CP4 cells contain a signiﬁcant lower amount of 40S ribosomal subunits. P-value was obtained by using a one-sided Student’s t-test
(P<0.01). Quantitation was based on two independent experiments performed using two replicates.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 655faint bands are detected in this region. The low levels of
both 17S and 37S pre-rRNAs, together with the fact that
the 17S immediate upstream precursor, namely the 26S
pre-rRNA extending from sites 1 to 4b, was not detected
by probes P4 and P5 (Figure 5A and B) are strong indi-
cations that pathway C is a minor pathway in HEK293
cells.
An additional band with mobility similar to the
5.8S rRNA is detected with probe P5 (‘Asterisk’ in
Figure 5B). This band might correspond to a fragment
comprising from site 4b to an upstream site in ITS2 but
only if there would be a cryptic endonucleolytic cleavage
site downstream of site 4, which can now be speculated, fol-
lowing the recent discovery of the endonucleolytic activity
associated to the exosome, the main trans-acting factor re-
sponsible for maturation of the 5.8S rRNA 30-end (53).
Analysis of the pre-rRNA processing kinetics was per-
formed by metabolic labeling with [
32P]-orthophosphate
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656 Nucleic Acids Research, 2011,Vol. 39,No. 2(Figure 6). By visual analysis of the autoradiograph, it
is possible to observe the 21S pre-rRNA, although
faint, in NIP7-depleted cells at the 2h time point.
Quantitation of the bands and calculation of the ratio
relative to the amount of the 47S pre-rRNA revealed
that formation of the 34S pre-rRNA is reduced and
the 21S pre-rRNA is increased in NIP7-depleted
cells (Figure 6B), which is consistent with the
steady-state analyses, showing a defect in processing of
ITS1.
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Nucleic AcidsResearch, 2011, Vol.39,No. 2 657Primer extension analysis of pre-rRNA processing sites in
NIP7 deﬁcient cells
Primer extension analyses were performed to examine the
50-end of rRNA products at the processing sites that
appeared to be most affected according to the northern
blot analyses (Figure 7). Primer extension with oligo-
nucleotide PE1 complementary to a sequence in the 18S
rRNA, 27 bases downstream of the predicted 50-end of the
mature 18S rRNA (Site 1), resulted in products with the
expected size (57, 30nt of the primer PE1 plus 27nt of
extension up to Site 1). Interestingly, however, two
bands were observed for all samples, suggesting that the
cleavage at site 1 may take place at two adjacent nucleo-
tides. For the parental HEK293 cells and the control cells
transfected with the scrambled shRNA, the two bands
showed a 1:1 ratio (Figure 7A). NIP7-depleted cells
showed different product ratios with a sharp reduction
of the longer product (Figure 7A). These discrepancies
are consistent with defective processing at site 1 in
NIP7-depleted cells. Oligonucleotide PE2 complementary
to a sequence in ITS1 (nt 6299–6324 in the pre-rRNA)
downstream of probe P3 (complementary to ITS1 nt
6121–6160 in the pre-rRNA) was used to determine the
efﬁciency of cleavage reactions at sites in ITS1. Extension
of primer PE2 generated a product of 33nt (26nt of the
primer and 7nt of extension), which corresponds to the
50-end of the pre-rRNAs generated by cleavage at site 2b
(Figure 7B). A reduction in the primer extension product
is observed in NIP7-depleted cells, corroborating the
results of the northern hybridizations which show inhib-
ition of cleavages in ITS1 as a consequence of the reduced
levels of NIP7. Oligonucleotide PE3 is complementary to
a sequence 32 bases downstream of site 3, the predicted
50-end of the mature 5.8S rRNA (nt 6655–6682 in the
pre-rRNA). Extension of primer PE3 generated two
major products, one with 60nt (28nt of the primer plus
32nt of extension), corresponding to the expected size of
the product generated by cleavage at site 3 and another
one, 8–10nt longer, designated as 3L (Figure 7C). In eu-
karyotes, the 50-end of the 5.8S rRNA has been described
as heterogeneous (54–56) and this result suggests that
mammalians may have at least a second form of 5.8S
rRNA showing extended 50-end as observed for
S. cerevisiae (57). Similarly to the extension of primers
PE1 and PE2, knocking down NIP7 expression caused a
reduction especially of the longer extension products at
site 3. The primer extension results, therefore, conﬁrm
the observation described above that lowering NIP7 ex-
pression leads to defects in pre-rRNA processing, affect-
ing more strongly processing of the 50-ETS and ITS1
spacer sequences.
Extension of primer PE3 revealed also three additional
products (Figure 7C) that end at positions U7, U14 and
A17 of the mature 5.8S rRNA (shorter form). The 5.8S
rRNA is known to be methylated at residues U14 and
G77, so we can assume that the faint band at the U14
position is a primer extension stop due to methylation.
There is no report in the literature about nucleotide or
base modiﬁcation at positions A17 and U7 of the
mature 5.8S rRNA. Primer extension stops can be
originated when the reverse transcriptase reaches 50-ends,
base/ribose modiﬁcations or highly stable secondary
structures. The band at position A17 is barely detectable
in control cells and increases in NIP7-depleted cells,
suggesting that it results from NIP7 deﬁciency
(Figure 7C). In this case it is possible to speculate that
the stop was due to premature degradation of the
5.8S rRNA 50-end in the context of NIP7 deﬁciency
where the aberrant and misprocessed precursors might
be directed for degradation. In case of stop at
position U7, it is present in control and test cells and is
therefore caused by something that is common to the three
samples which could be any of the options mentioned
above.
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Nucleic AcidsResearch, 2011, Vol.39,No. 2 659Human NIP7 associates to nuclear pre-ribosomal particles
Western blot analysis of the distribution of NIP7 in
sucrose gradient fractions using the regular protocol to
isolate polysomal extracts (51) revealed that NIP7
co-sediments in the range of 60S–80S ribosomes
(Figure 8B). This result is similar to the distribution of
S. cerevisiae Nip7p in sucrose gradients (40). However,
previous data indicated that human NIP7 is a nucleolar
protein (43). Cell fractionation followed by immunoblot
analysis can be used to determine protein subcellular lo-
calization with a reasonable accuracy that, in some cases,
can complement immunoﬂuorescence assays or localiza-
tion based on fusion to ﬂuorescent proteins. Therefore,
cell fractionation experiments were performed and con-
ﬁrmed that NIP7 is restricted to the nuclear compartment
(Figure 8C). In a second experiment the sucrose gradient
fractionation was performed with nuclear extract. A
regular sucrose gradient with whole-cell polysomal
extract was performed in parallel so that the positions of
the 40S and 60S ribosomal subunits, 80S ribosomes and
polysomes of the whole-cell polysomal extracts could
serve as reference for sedimentation of the nuclear
pre-ribosomal complexes. The fractionation analysis of
the nuclear extract on sucrose gradients revealed that
NIP7 distribution is highly similar to the proﬁle
observed for its distribution in the gradient of the
whole-cell extract (Figure 8, compare panels B and D),
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Figure 8. Analysis of NIP7 sedimentation on sucrose density gradients. (A) Polysome proﬁle of HEK293 whole-cell polysomal extracts prepared
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660 Nucleic Acids Research, 2011,Vol. 39,No. 2further suggesting that NIP7 co-sediments with
pre-ribosomal particles. The control proteins used in
these analyses showed the expected distribution. In the
whole-cell extract gradient, RPS6 co-sediments in two
major peaks, one between fractions 5 and 8, where the
free 40S subunits and 80S ribosomes sediment, and
between fractions 10 and 13, associated with polysomes
(Figure 8B). In the gradient of nuclear extracts, on the
other hand, most of RPS6, sediments in fractions 2 and
3, either as a soluble protein or as part of small complexes
(Figure 8D). A smaller fraction of RPS6 sediments in frac-
tions 5–9, indicating that it is associated to pre-ribosomal
particles (Figure 8D). Lamin A/C was used as nuclear
marker and behaves as a soluble protein in the sucrose
gradient of the nuclear extract (Figure 8D). Consistently
with the results shown above, NIP7 co-sediments with
particles corresponding to pre-ribosomes in nuclear
extracts gradients (Figure 8D). Combined, these results
strongly indicate that NIP7 binds pre-ribosome particles
in the nucleolus, thereby participating in the early
pre-rRNA processing reactions.
Human NIP7 interacts with poly-U and poly-AU
RNAs in vitro
The S. cerevisiae and P. abyssi Nip7 orthologs interact
in vitro preferentially with poly-U homopolymers (42)
and with poly-AU (J. S. Luz and C. C. Oliveira,
personal communication). In order to determine whether
recombinant human NIP7 also binds to RNA we initially
tested its interaction with poly-U using electrophoretic
mobility shift assays under native conditions. These
assays showed that human NIP7 binds to polyuridine se-
quences although with low afﬁnity (Figure 9A).
Subsequent experiments showed that the human NIP7
protein binds to poly-AU with higher afﬁnity than to
poly-U (Figure 9B). In addition, competition assays
were performed with increasing concentrations of un-
labeled poly-A and poly-AU oligonucleotides. An excess
of poly-A did not show effect on the NIP7–poly-AU inter-
action while the intensity of the band shift was reduced by
increasing concentrations of unlabeled poly-AU oligo-
nucleotides (Figure 9B and C), conﬁrming the speciﬁcity
of the NIP7–poly-AU interaction. The poly-AU oligo-
nucleotide can form intra and intermolecular base-pairing
suggesting that NIP7 might have a higher afﬁnity for
structured RNAs.
DISCUSSION
Given the essential function of the S. cerevisiae NIP7 gene
(40), the high conservation of NIP7 orthologs and the as-
sociation to other ribosome synthesis proteins, we could
predict that NIP7 would play an important function in
human cells. We applied the RNA interference experimen-
tal approach to downregulate NIP7 expression and search
for loss-of-function phenotypes. Downregulation of NIP7
in HEK293 cells was efﬁciently obtained using the
transposon-based delivery system described by
Heggestad et al. (49). Downregulation of NIP7 in
HEK293, MCF10A and HeLa cells leads to reduction of
cell proliferation rates, with cells accumulating in the G1
phase, indicating that NIP7 plays an important role in all
human cells. Downregulation of NIP7 in HEK293 cells
affected the levels of 40S ribosomal subunits and caused
alterations in pre-rRNA processing which affected
mainly the levels of the 34S, 26S and 21S pre-rRNA
intermediates. Reduction of the 34S pre-rRNA indicates
a slow processing defect at sites 2b and 2c. The increase
of the 26S pre-rRNA concentration also correlates with
slow processing of site 1 and of sites 2/2b whereas the
increase of the 21S pre-rRNA indicates slow processing
at sites 2/2b. Primer extension analysis of sites 1, 2b and
3 further supports the northern blot data. At least part
of the pre-rRNA processing defects caused by NIP7 de-
pletion have been described for other situations in which
ribosome biogenesis was impaired, such as treatment
with leptomycin B, which inhibits exportin Crm1/Xpo1
and blocks ribosome subunit export from the nucleus,
and for knockdown of 40S biogenesis factors (11). The
data obtained in this study indicate that human NIP7 is
required primarily for processing of the pre-rRNA inter-
mediates leading to the synthesis of the 18S rRNA and
40S subunit. Taking into account the conditional deple-
tion of yeast Nip7p leads to a deﬁcit of 60S subunits and
to accumulation of the 27S pre-rRNA (40), during the
course of this work, we have tested whether the human
and archaeal NIP7 orthologs could complement a yeast
Dnip7 mutant strain (Supplementary Figure S1). This
analysis showed that neither the human nor the
archaeal NIP7 ortholog can complement a yeast Dnip7
strain. This ﬁnding indicates that although the three
orthologs bind structured RNA, and the yeast and
human NIP7 are involved in pre-rRNA processing, the
function of yeast Nip7p is not fully conserved in human
cells.
The interactions of human NIP7 with other proteins are
consistent with its role in ribosome biosynthesis. The ﬁrst
interaction described was with Nop132 (43), the putative
ortholog of the S. cerevisiae Nop8p (44). Tests using the
yeast two hybrid system and GST pull-down assays
detected association of NIP7 with SBDS, indicating that
both proteins may be part of a multisubunit complex (47).
Subsequently, human NIP7 was found in association with
complexes isolated by afﬁnity-tagged puriﬁcation of the
40S subunit protein RPS19 (45). This protein was
already shown to play an essential role in 40S subunit
biosynthesis in human cells (23), consistently with the
genetic ﬁndings that link mutations in the RPS19 gene
to the DBA (25). Orru ` and co-workers (45) described
159 proteins that co-purify with GST-RPS19. Although
this complex is heterogeneous, it contains structural com-
ponents of both the 40S and 60S subunits and a large set
of proteins already known to function in ribosome synthe-
sis. NIP7 is also found in complexes isolated by
afﬁnity-tagged puriﬁcation of parvulin (Par14), a
peptidyl-prolyl cis–trans isomerase (PPIase) reported to
function in pre-rRNA processing (46). These large
complexes are found mostly in the nucleolus, although
some components may be found throughout the whole
nucleus, consistently with our data describing NIP7 in
the nuclear extracts that sediment in sucrose gradients
Nucleic AcidsResearch, 2011, Vol.39,No. 2 661with molecular masses in the range of 40S–80S ribosomes.
During the development of this work, it became clear that
the cell extracts used in the sucrose gradient fractionations
contained nuclear and nucleolar contaminants probably
due to partial leakage of nuclear content during disruption
of cells under the hypotonic buffer conditions used or due
to partial disruption of nuclei by the 1% v/v Triton deter-
gent that is added to the extraction buffer. Cell fraction-
ation revealed NIP7 only in the nuclear fraction and
sucrose gradient fractionation of nuclear extracts
indicated that NIP7 co-sediments with high molecular
complexes, consistently with its association to
pre-ribosomal particles.
Depletion of S. cerevisiae Nip7p caused a general defect
in pre-rRNA processing, with accumulation of normal
(35S and 27S) and of the aberrant (23S) pre-rRNAs and
a reduction in the concentration of the mature rRNAs.
Despite the global defects on pre-rRNA processing,
S. cerevisiae Nip7p depletion led to a deﬁcit of 60S
subunit (40) and was found in 60S complexes (58). In
addition, S. cerevisiae Nip7p interacts with a group of
proteins involved in ribosome synthesis, including the
exosome subunit Rrp43p and the nucleolar proteins
Nop8p, Nop53p and Sdo1p (37,44,59,60). These proteins
have been implicated to 60S subunit synthesis, although it
is important to point out that conditional depletion of the
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Figure 9. Analysis of NIP7 interaction with RNA in vitro.( A) Autoradiography of an electrophoretic mobility shift assay to determine the inter-
action of NIP7 with poly-U. One picomole of [
32P]-labeled poly-A(20) (negative control) and poly-U(20) were incubated with 100pmol of recombinant
NIP7. pU indicates the positive control in the assay containing [
32P]-labeled poly-U(20) and S. cerevisiae Nip7p. The arrow indicates the shifted bands
corresponding to the complexes formed by NIP7 and yeast Nip7p with poly-U. (B) Autoradiography of an electrophoretic mobility shift assay
showing the interaction of NIP7 with poly-AU. A total of 0.4pmol of a [
32P]-labeled 21 mer poly-AU was incubated with 100, 200 and 400pmol of
recombinant NIP7 (lanes 2–4 and 9–11) showing NIP7 concentration dependent complex formation. Parallel competition experiments were per-
formed. In lanes 5–7, 1, 5 and 10pmol of cold poly-A were used as competitors. No effect of polyA addition is observed on the formation of
poly-AU/NIP7 complexes. In lanes 12–14, 1, 5 and 10pmol of cold poly-AU were used as competitor. As expected, a reduction of poly-AU/NIP7
complex formation is observed. (C) Graphs showing the quantitation of the ratio between the amount of polyAU-NIP7 complexes and the amount
of free poly-AU of the experiment shown in (B). To calculate the relative intensities, the value of lane 4 was taken as 100% for the binding reactions
from lanes 1 to 7 (graph on the left) and the value of lane 11 and taken as 100% for the binding reactions from lanes 8 to 14 (graph on the right).
662 Nucleic Acids Research, 2011,Vol. 39,No. 2exosome subunit Rrp43p also led to general defects in
pre-rRNA processing resulting in deﬁcit of 40S ribosomal
subunits (60). This phenotype is highly unexpected,
given that exosome components have previously been
reported to be required for excision of the ITS2 segment
during maturation of the 30-end of the 5.8S rRNA, a com-
ponent of the 60S subunit (61). Further analysis of
Rrp43p-depleted cells (60) and of temperature sensitive
mutant strains (62) conﬁrmed that deﬁciency of Rrp43p
causes global defects in pre-rRNA processing, making it
difﬁcult to distinguish the primary from the secondary
defects based only on data obtained from conditional
mutants.
Despite the discrepancies between the defects observed
in yeast and human NIP7 deﬁcient cells, both human and
yeast NIP7 proteins share the ability to bind poly-U
in vitro, although human NIP7 has shown higher afﬁnity
for a poly-AU oligoribonucleotide. NIP7 cognate RNA
target sequences have not been identiﬁed yet and its pref-
erence for binding to poly-U and poly-AU suggests that it
might interact with uridine-rich sequences of the
pre-rRNA similarly to Rrp5p, which was described to
interact with a uridine-rich sequence in the ITS1 of the
S. cerevisiae pre-rRNA (63). NIP7 orthologs share a
two-domain architecture with the C-terminal PUA
domain mediating interaction with RNA (42). This
domain organization, suggests that NIP7 is an adaptor
protein with the C-terminal domain interacting with
RNA targets and the N-terminal domain mediating inter-
action with protein targets.
Saccharomyces cerevisiae NIP7 is part of the Ribi
regulon (13,15) and its transcription levels were also
shown to correlate with other Ribi regulon genes in
response to stress caused by the alkylating agent methyl
methanesulfonate (64). In addition, a study based on the
analysis of gene expression in response to abrupt changes
in environmental conditions has associated S. cerevisiae
NIP7 to the early repressed ribosomal genes (65). As for
the human NIP7 gene, its core promoter contains the 50-C
ACGTG-30 sequence, also known as E(CG) sequence (66),
that is recognized by the Myc:Max heterodimer,
indicating that NIP7 is part of the human Ribi regulon
proposed to be under control of the Myc transcription
factor (16–18).
In conclusion, the data presented in this study show
that human NIP7 plays an important role for cell pro-
liferation and implicate NIP7 primarily in the
processing of pre-rRNA intermediates leading to mat-
uration of the 18S rRNA and 40S ribosomal subunit
biosynthesis. The pre-rRNA processing defects clearly
indicate that NIP7 plays a critical role in pre-rRNA pro-
cessing in human cells. Association of NIP7 to RPS19
complexes (45) helps to explain the pre-RNA pro-
cessing defects of the 18S rRNA pathway observed in
this work for NIP7-depleted cells. We also show
evidence that the human NIP7 protein is restricted
to the nuclear compartment and that its sedimenta-
tion pattern in sucrose gradient fractionation indi-
cates that it is associated to nuclear pre-ribosomal
complexes.
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